Feasibility of Coronary Access in Patients With Acute Coronary Syndrome and Previous TAVR.

[1]  M. Leon,et al.  Coronary Cannulation After Transcatheter Aortic Valve Replacement: The RE-ACCESS Study. , 2020, JACC. Cardiovascular interventions.

[2]  R. Makkar,et al.  Coronary Access After TAVR. , 2020, JACC. Cardiovascular interventions.

[3]  M. Buchbinder,et al.  Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients. , 2020, JACC. Cardiovascular interventions.

[4]  J. Rodés‐Cabau,et al.  Interaction Between Self-Expanding Transcatheter Heart Valves and Coronary Ostia: An Angiographically Based Analysis of the Evolut R/Pro Valve System. , 2020, The Journal of invasive cardiology.

[5]  M. Desai,et al.  Incidence and Outcomes of Acute Coronary Syndrome After Transcatheter Aortic Valve Replacement. , 2020, JACC. Cardiovascular interventions.

[6]  B. García del Blanco,et al.  Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement , 2020, Circulation. Cardiovascular interventions.

[7]  G. Tarantini,et al.  Incidence and feasibility of coronary access after transcatheter aortic valve replacement , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  B. Prendergast,et al.  Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. , 2019, European heart journal.

[9]  R. Puri,et al.  Clinical and Technical Characteristics of Coronary Angiography and Percutaneous Coronary Interventions Performed before and after Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve , 2019, Journal of interventional cardiology.

[10]  J. Leipsic,et al.  Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[11]  A. Colombo,et al.  Incidence, Technical Safety, and Feasibility of Coronary Angiography and Intervention Following Self-expanding Transcatheter Aortic Valve Replacement. , 2019, Cardiovascular revascularization medicine : including molecular interventions.

[12]  F. Maes,et al.  Incidence, Clinical Characteristics, and Impact of Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement. , 2018, JACC. Cardiovascular interventions.

[13]  C. Grines,et al.  Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic™ self‐expandable bioprosthetic valve , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  C. Vassanelli,et al.  Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation. , 2017, The American journal of cardiology.

[15]  J. Dubois-Randé,et al.  Coronary Procedures After TAVI With the Self‐Expanding Aortic Bioprosthesis Medtronic CoreValve™, Not an Easy Matter , 2017, Journal of interventional cardiology.

[16]  G. Richardt,et al.  Incidence, feasibility and outcome of percutaneous coronary intervention after transcatheter aortic valve implantation with a self-expanding prosthesis. Results from a single center experience. , 2016, Cardiovascular revascularization medicine : including molecular interventions.

[17]  Á. Avezum,et al.  Predictors of hospital mortality in the global registry of acute coronary events. , 2003, Archives of internal medicine.

[18]  J. Boura,et al.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials , 2003, The Lancet.